Canada Markets closed

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0500+0.0100 (+25.00%)
At close: 10:33AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.56
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.1300
52 Week Low 30.0200
50-Day Moving Average 30.0566
200-Day Moving Average 30.0750

Share Statistics

Avg Vol (3 month) 352.55k
Avg Vol (10 day) 321.3k
Shares Outstanding 5132.63M
Implied Shares Outstanding 6N/A
Float 8119.63M
% Held by Insiders 114.66%
% Held by Institutions 10.00%
Shares Short (Jul 14, 2022) 440.22k
Short Ratio (Jul 14, 2022) 44
Short % of Float (Jul 14, 2022) 4N/A
Short % of Shares Outstanding (Jul 14, 2022) 40.03%
Shares Short (prior month Jun 14, 2022) 421.21k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -83.35%
Operating Margin (ttm)-75.94%

Management Effectiveness

Return on Assets (ttm)-29.86%
Return on Equity (ttm)-144.05%

Income Statement

Revenue (ttm)2.53M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-38.50%
Gross Profit (ttm)2.69M
EBITDA -1.91M
Net Income Avi to Common (ttm)-2.1M
Diluted EPS (ttm)-0.0110
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.28M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)2.21M
Total Debt/Equity (mrq)247.53
Current Ratio (mrq)1.09
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.26M
Levered Free Cash Flow (ttm)-706.9k